Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Primary sclerosing cholangitis - the Norwegian experience.

Schrumpf E, Boberg KM, Karlsen TH.

Scand J Gastroenterol. 2015 Apr 12:1-16. [Epub ahead of print]

PMID:
25866138
2.

Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.

Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygård S, Godang K, Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH, Lund-Johansen F, Syversveen T, Brabrand K, Parés A, Ponsioen CY, Pinzani M, Färkkilä M, Moum B, Ueland T, Røsjø H, Rosenberg W, Boberg KM, Karlsen TH.

Hepatology. 2015 Apr 1. doi: 10.1002/hep.27825. [Epub ahead of print]

PMID:
25833813
3.

Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complications.

Thorsen T, Dahlgren US, Aandahl EM, Grzyb K, Karlsen TH, Boberg KM, Rydberg L, Naper C, Foss A, Bennet W.

Transpl Int. 2015 Mar 3. doi: 10.1111/tri.12552. [Epub ahead of print]

PMID:
25736519
4.

Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis.

Berntsen NL, Klingenberg O, Juran BD, Benito de Valle M, Lindkvist B, Lazaridis KN, Boberg KM, Karlsen TH, Hov JR.

Gastroenterology. 2015 May;148(5):924-927.e2. doi: 10.1053/j.gastro.2015.01.041. Epub 2015 Feb 2.

PMID:
25655558
5.

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.

Andresen K, Boberg KM, Vedeld HM, Honne H, Jebsen P, Hektoen M, Wadsworth CA, Clausen OP, Lundin KE, Paulsen V, Foss A, Mathisen Ø, Aabakken L, Schrumpf E, Lothe RA, Lind GE.

Hepatology. 2015 May;61(5):1651-9. doi: 10.1002/hep.27707. Epub 2015 Feb 24.

PMID:
25644509
6.

Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.

Næss S, Lie BA, Melum E, Olsson M, Hov JR, Croucher PJ, Hampe J, Thorsby E, Bergquist A, Traherne JA, Schrumpf E, Boberg KM, Schreiber S, Franke A, Karlsen TH.

PLoS One. 2014 Dec 18;9(12):e114486. doi: 10.1371/journal.pone.0114486. eCollection 2014.

7.

Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study.

Åberg F, Gissler M, Karlsen TH, Ericzon BG, Foss A, Rasmussen A, Bennet W, Olausson M, Line PD, Nordin A, Bergquist A, Boberg KM, Castedal M, Pedersen CR, Isoniemi H.

Hepatology. 2015 Feb;61(2):668-77. doi: 10.1002/hep.27538. Epub 2015 Jan 5.

PMID:
25266201
8.

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.

Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM, Lind GE.

Int J Cancer. 2015 Feb 15;136(4):844-53. doi: 10.1002/ijc.29039. Epub 2014 Jun 28.

9.

HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH.

World J Gastroenterol. 2014 Apr 14;20(14):3986-4000. doi: 10.3748/wjg.v20.i14.3986.

10.

Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.

Naess S, Björnsson E, Anmarkrud JA, Al Mamari S, Juran BD, Lazaridis KN, Chapman R, Bergquist A, Melum E, Marsh SG, Schrumpf E, Lie BA, Boberg KM, Karlsen TH, Hov JR.

Liver Int. 2014 Nov;34(10):1488-95. doi: 10.1111/liv.12492. Epub 2014 Mar 7.

PMID:
24517468
11.

Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.

Karlsen TH, Vesterhus M, Boberg KM.

Aliment Pharmacol Ther. 2014 Feb;39(3):282-301. doi: 10.1111/apt.12581. Epub 2013 Dec 29. Review.

PMID:
24372568
12.

Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?

Block M, Jørgensen KK, Oresland T, Lindholm E, Grzyb K, Cvancarova M, Vatn MH, Boberg KM, Börjesson L.

J Crohns Colitis. 2014 May 1;8(5):421-30. doi: 10.1016/j.crohns.2013.10.008. Epub 2013 Nov 12.

13.

Liver abnormalities in bowel diseases.

Kummen M, Schrumpf E, Boberg KM.

Best Pract Res Clin Gastroenterol. 2013 Aug;27(4):531-42. doi: 10.1016/j.bpg.2013.06.013. Review.

PMID:
24090940
14.

Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis.

Andersen IM, Tengesdal G, Lie BA, Boberg KM, Karlsen TH, Hov JR.

Clin Gastroenterol Hepatol. 2014 Jun;12(6):1019-28. doi: 10.1016/j.cgh.2013.09.024. Epub 2013 Sep 25.

PMID:
24076415
15.

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Wannhoff A, Hov JR, Folseraas T, Rupp C, Friedrich K, Anmarkrud JA, Weiss KH, Sauer P, Schirmacher P, Boberg KM, Stremmel W, Karlsen TH, Gotthardt DN.

J Hepatol. 2013 Dec;59(6):1278-84. doi: 10.1016/j.jhep.2013.08.005. Epub 2013 Aug 16.

PMID:
23958938
16.

Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.

Boberg KM, Wisløff T, Kjøllesdal KS, Støvring H, Kristiansen IS.

Aliment Pharmacol Ther. 2013 Oct;38(7):794-803. doi: 10.1111/apt.12435. Epub 2013 Aug 5.

PMID:
23915021
17.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium; International IBD Genetics Consortium, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN; International PSC Study Group, Franke A, Anderson CA, Karlsen TH.

Nat Genet. 2013 Jun;45(6):670-5. doi: 10.1038/ng.2616. Epub 2013 Apr 21.

18.

Update on primary sclerosing cholangitis.

Karlsen TH, Boberg KM.

J Hepatol. 2013 Sep;59(3):571-82. doi: 10.1016/j.jhep.2013.03.015. Epub 2013 Apr 18. Review.

19.

Liver transplantation for nonresectable liver metastases from colorectal cancer.

Hagness M, Foss A, Line PD, Scholz T, Jørgensen PF, Fosby B, Boberg KM, Mathisen O, Gladhaug IP, Egge TS, Solberg S, Hausken J, Dueland S.

Ann Surg. 2013 May;257(5):800-6. doi: 10.1097/SLA.0b013e3182823957.

PMID:
23360920
20.

Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.

Lindström L, Hultcrantz R, Boberg KM, Friis-Liby I, Bergquist A.

Clin Gastroenterol Hepatol. 2013 Jul;11(7):841-6. doi: 10.1016/j.cgh.2012.12.032. Epub 2013 Jan 22.

PMID:
23353641
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk